{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Motor neuron disease", "Mutant PFN1 aggregation", "Spinal cord", "Transgenic mutant PFN1 mice"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34925718", "DateRevised": {"Year": "2022", "Month": "04", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "01"}], "Language": ["eng"], "ELocationID": ["10.32598/bcn.12.2.1631.1"], "Journal": {"ISSN": "2008-126X", "JournalIssue": {"Volume": "12", "Issue": "2", "PubDate": {"Year": "2021", "Season": "Mar-Apr"}}, "Title": "Basic and clinical neuroscience", "ISOAbbreviation": "Basic Clin Neurosci"}, "ArticleTitle": "Mutant Profilin1 Aggregation in Amyotrophic Lateral Sclerosis: An in Vivo Biochemical Analysis.", "Pagination": {"StartPage": "213", "EndPage": "222", "MedlinePgn": "213-222"}, "Abstract": {"AbstractText": ["Profilin1 (PFN1) is a ubiquitously expressed protein known for its function as a regulator of actin polymerization and dynamics. A recent discovery linked mutant PFN1 to Amyotrophic Lateral Sclerosis (ALS), which is a fatal and progressive motor neuron disease. We have also demonstrated that Gly118Val mutation in PFN1 is a cause of ALS, and the formation of aggregates containing mutant PFN1 may be a mechanism for motor neuron death. Hence, we were interested in investigating the aggregation of PFN1 further and searching for co-aggregated proteins in our mouse model overexpressing mutant PFN1.", "We investigated protein aggregation in several tissues of transgenic and notransgenic mice using western blotting. To further understand the neurotoxicity of mutant PFN1, we conducted a pull-down assay using an insoluble fraction of spinal cord lysates from hPFN1<sup>G118V</sup> transgenic mice. For this assay, we expressed His<sub>6</sub>-tagged PFN1<sup>WT</sup> and PFN1<sup>G118V</sup> in E. coli and purified these proteins using the Ni-NTA column.", "In this study, we demonstrated that mutant PFN1 forms aggregate in the brain and spinal cord of hPFN1<sup>G118V</sup> mice, while WT-PFN1 remains soluble. Among these tissues, spinal cord lysates were found to have PFN1 bands at higher molecular weights recognized with anti-PFN1. Moreover, the pull-down assay using His<sub>6</sub>-PFN1<sup>G118V</sup> showed that Myelin Binding Protein (MBP) was present in the insoluble fraction.", "Our analysis of PFN1 aggregation in vivo revealed further details of mutant PFN1 aggregation and its possible complex formation with other proteins, providing new insights into the ALS mechanism."], "CopyrightInformation": "Copyright\u00a9 2021 Iranian Neuroscience Society."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran."}], "LastName": "Nekouei", "ForeName": "Mina", "Initials": "M"}, {"Identifier": ["0000-0002-1723-3914"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran."}], "LastName": "Aliahmadi", "ForeName": "Atousa", "Initials": "A"}, {"Identifier": ["0000-0002-0802-1426"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Department of Neurology, Department of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, USA."}], "LastName": "Kiaei", "ForeName": "Mahmoud", "Initials": "M"}, {"Identifier": ["0000-0002-6435-9915"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran."}], "LastName": "Ghassempour", "ForeName": "Ali Reza", "Initials": "AR"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "Basic Clin Neurosci", "NlmUniqueID": "101575211", "ISSNLinking": "2008-126X"}, "CoiStatement": "Conflict of interest Dr. Kiaei and UAMS have a financial interest in the technology discussed in this paper. These budgetary interests have been reviewed and affirmed as per the UAMS conflict of interest policies. Other authors have declared no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Al-Chalabi A., van den Berg L. H., Veldink J. (2017). Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management. Nature Reviews Neurology, 13(2), 96\u2013104. [DOI:10.1038/nrneurol.2016.182]", "ArticleIdList": ["10.1038/nrneurol.2016.182", "27982040"]}, {"Citation": "Alkam D., Feldman E. Z., Singh A., Kiaei M. (2017). Profilin1 biology and its mutation, actin(g) in disease. Cellular and Molecular Life Sciences, 74(6), 967\u201381. [DOI:10.1007/s00018-016-2372-1]", "ArticleIdList": ["10.1007/s00018-016-2372-1", "PMC5311022", "27669692"]}, {"Citation": "Boggs J. (2006). Myelin basic protein: A multifunctional protein. Cellular and Molecular Life Sciences, 63(17), 1945\u201361. [DOI:10.1007/s00018-006-6094-7]", "ArticleIdList": ["10.1007/s00018-006-6094-7", "16794783"]}, {"Citation": "Bondarev S., Antonets K., Kajava A., Nizhnikov A., Zhouravleva G. (2018). Protein co-aggregation related to amyloids: methods of investigation, diversity, and classification. International Journal of Molecular Sciences, 19(8), 2292. [DOI:10.3390/ijms19082292]", "ArticleIdList": ["10.3390/ijms19082292", "PMC6121665", "30081572"]}, {"Citation": "Boopathy S., Silvas T. V., Tischbein M., Jansen S., Shandilya S. M., Zitzewitz J. A., et al. (2015). Structural basis for mutation-induced destabilization of profilin 1 in ALS. Proceedings of the National Academy of Sciences of the United States of America, 112(26), 7984\u201389. [DOI:10.1073/pnas.1424108112]", "ArticleIdList": ["10.1073/pnas.1424108112", "PMC4491777", "26056300"]}, {"Citation": "Brettle M., Suchowerska A. K., Chua S. W., Ittner L. M., Fath T. (2015). Amyotrophic lateral sclerosis-associated mutant profilin 1 increases dendritic arborisation and spine formation in primary hippocampal neurons. Neuroscience Letter, 609, 223\u20138. [DOI:10.1016/j.neulet.2015.09.034]", "ArticleIdList": ["10.1016/j.neulet.2015.09.034", "26499959"]}, {"Citation": "Chen Y., Zheng Z. Z., Huang R., Chen K., Song W., Zhao B., et al. (2013). PFN1 mutations are rare in Han Chinese populations with amyotrophic lateral sclerosis. Neurobiology of Aging, 34(7), 1922\u2013e1. [DOI:10.1016/j.neurobiolaging.2013.01.013]", "ArticleIdList": ["10.1016/j.neurobiolaging.2013.01.013", "23428184"]}, {"Citation": "Del Poggetto E., Bemporad F., Tatini F., Chiti F. (2015). Mutations of Profilin-1 associated with amyotrophic lateral sclerosis promote aggregation due to structural changes of its native state. ACS Chemical Biology, 10(11), 2553\u201363. [DOI:10.1021/acschembio.5b00598]", "ArticleIdList": ["10.1021/acschembio.5b00598", "26226631"]}, {"Citation": "Del Poggetto E., Gori L., Chiti F. (2016). Biophysical analysis of three novel profilin-1 variants associated with amyotrophic lateral sclerosis indicates a correlation between their aggregation propensity and the structural features of their globular state. Biological Chemistry, 397(9), 927\u201337. [DOI:10.1515/hsz-2016-0154]", "ArticleIdList": ["10.1515/hsz-2016-0154", "27101547"]}, {"Citation": "Del Poggetto E., Toto A., Aloise C., Di Piro F., Gori L., Malatesta F., et al. (2018). Stability of an aggregation-prone partially folded state of human profilin-1 correlates with aggregation propensity. Journal of Biological Chemistry, 293(26), 10303\u20131031. [DOI:10.1074/jbc.RA118.002087]", "ArticleIdList": ["10.1074/jbc.RA118.002087", "PMC6028969", "29760185"]}, {"Citation": "Fil D., DeLoach A., Yadav S., Alkam D., MacNicol M., Singh A., et al. (2017). Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease. Human Molecular Genetics, 26(4), 686\u2013701. [DOI:10.1093/hmg/ddw429]", "ArticleIdList": ["10.1093/hmg/ddw429", "PMC5968635", "28040732"]}, {"Citation": "Freischmidt A., Schopflin M., Feiler M. S., Fleck A. K., Ludolph A. C., Weishaupt J. H. (2015). Profilin 1 with the amyotrophic lateral sclerosis associated mutation T109M displays unaltered actin binding and does not affect the actin cytoskeleton. BMC Neuroscience, 16(1), 77. [DOI:10.1186/s12868-015-0214-y]", "ArticleIdList": ["10.1186/s12868-015-0214-y", "PMC4647582", "26572741"]}, {"Citation": "Frid K., Einstein O., Friedman-Levi Y., Binyamin O., Ben-Hur T., Gabizon R. (2015). Aggregation of MBP in chronic demyelination. Annals of Clinical and Translational Neurology, 2(7), 711\u201321. [DOI:10.1002/acn3.207]", "ArticleIdList": ["10.1002/acn3.207", "PMC4531054", "26273684"]}, {"Citation": "Harauz G., Ladizhansky V., Boggs J. M. (2009). Structural polymorphism and multifunctionality of myelin basic protein. Biochemistry, 48(34), 8094\u2013104. [DOI:10.1021/bi901005f]", "ArticleIdList": ["10.1021/bi901005f", "19642704"]}, {"Citation": "Hardiman O., Al-Chalabi A., Chio A., Corr E. M., Logroscino G., Robberecht W., et al. (2017). Amyotrophic lateral sclerosis. Nature Reviews Disease Primers, 3, 17071\u201385. [DOI:10.1038/nrdp.2017.85]", "ArticleIdList": ["10.1038/nrdp.2017.85", "29052611"]}, {"Citation": "Ingre C., Landers J. E., Rizik N., Volk A. E., Akimoto C., Birve A., et al. (2013). A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts. Neurobiology of Aging, 34(6), 1708-e1. [DOI:10.1016/j.neurobiolaging.2012.10.009]", "ArticleIdList": ["10.1016/j.neurobiolaging.2012.10.009", "PMC6591725", "23141414"]}, {"Citation": "Jockusch B. M., Murk K., Rothkegel M. (2007). The profile of profilins. Reviews of Physiology, Biochemistry and Pharmacology, 131\u201349. [DOI:10.1007/112_2007_704]", "ArticleIdList": ["10.1007/112_2007_704", "17682948"]}, {"Citation": "Kiaei M. (2013). New hopes and challenges for treatment of neurodegenerative disorders: Great opportunities for young neuroscientists. Basic and Clinical Neuroscience, 4(1), 3\u20134.", "ArticleIdList": ["PMC4202552", "25337322"]}, {"Citation": "Kiaei M., Balasubramaniam M., Govind Kumar V., Shmookler Reis R. J., Moradi M., Varughese K. I. (2018). ALS-causing mutations in profilin-1 alter its conformational dynamics: A computational approach to explain propensity for aggregation. Scientific Reports, 8(1), 13102. [DOI:10.1038/s41598-018-31199-7]", "ArticleIdList": ["10.1038/s41598-018-31199-7", "PMC6117255", "30166578"]}, {"Citation": "Laemmli U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680\u20135. [DOI:10.1038/227680a0]", "ArticleIdList": ["10.1038/227680a0", "5432063"]}, {"Citation": "Louche A., Salcedo S. P., Bigot S. (2017). Protein-protein interactions: Pull-down assays. German: Springer. [DOI:10.1007/978-1-4939-7033-9_20]", "ArticleIdList": ["10.1007/978-1-4939-7033-9_20", "28667618"]}, {"Citation": "Nekouei M., Ghezellou P., Aliahmadi A., Arjmand S., Kiaei M., Ghassempour A. (2018). Changes in biophysical characteristics of PFN1 due to mutation causing amyotrophic lateral sclerosis. Metabolic Brain Disease, 33(6), 1975\u201384. [DOI:10.1007/s11011-018-0305-4]", "ArticleIdList": ["10.1007/s11011-018-0305-4", "PMC6230493", "30203378"]}, {"Citation": "Shevchenko A., Tomas H., Havlis J., Olsen J. V., Mann M. (2007). In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nature Protocols, 1(6), 2856\u20130. [DOI:10.1038/nprot.2006.468]", "ArticleIdList": ["10.1038/nprot.2006.468", "17406544"]}, {"Citation": "Smith B. N., Vance C., Scotter E. L., Troakes C., Wong C. H., Topp S., et al. (2015). Novel mutations support a role for Profilin 1 in the pathogenesis of ALS. Neurobiology of Aging, 36(3), 1602-e17. [DOI:10.1016/j.neurobiolaging.2014.10.032]", "ArticleIdList": ["10.1016/j.neurobiolaging.2014.10.032", "PMC4357530", "25499087"]}, {"Citation": "Tanaka Y., Hasegawa M. (2016). Profilin 1 mutants form aggregates that induce accumulation of prion-like TDP-43. Prion, 10(4), 283\u20139. [DOI:10.1080/19336896.2016.1207033]", "ArticleIdList": ["10.1080/19336896.2016.1207033", "PMC5082967", "27432186"]}, {"Citation": "Tanaka Y., Nonaka T., Suzuki G., Kametani F., Hasegawa M. (2016). Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation. Human Molecular Genetics, 25(7), 1420\u201333. [DOI:10.1093/hmg/ddw024]", "ArticleIdList": ["10.1093/hmg/ddw024", "26908597"]}, {"Citation": "Witke W. (2004). The role of profilin complexes in cell motility and other cellular processes. Trends in Cell Biology, 14(8), 461\u20139. [DOI:10.1016/j.tcb.2004.07.003]", "ArticleIdList": ["10.1016/j.tcb.2004.07.003", "15308213"]}, {"Citation": "Wu C. H., Fallini C., Ticozzi N., Keagle P. J., Sapp P. C., Piotrowska K., et al. (2012). Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature, 488(7412), 499\u2013503. [DOI:10.1038/nature11280]", "ArticleIdList": ["10.1038/nature11280", "PMC3575525", "22801503"]}, {"Citation": "Yang C., Danielson E. W., Qiao T., Metterville J., Brown R. H., Landers J. E., et al. (2016). Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity. Proceedings of the National Academy of Sciences, 113(41), E6209\u2013E6218. [DOI:10.1073/pnas.1605964113]", "ArticleIdList": ["10.1073/pnas.1605964113", "PMC5068285", "27681617"]}], "ReferenceList": []}], "History": [{"Year": "2019", "Month": "12", "Day": "15"}, {"Year": "2020", "Month": "1", "Day": "23"}, {"Year": "2020", "Month": "4", "Day": "6"}, {"Year": "2021", "Month": "12", "Day": "20", "Hour": "6", "Minute": "10"}, {"Year": "2021", "Month": "12", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "21", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "3", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34925718", "PMC8672666", "10.32598/bcn.12.2.1631.1", "bcn-12-213"]}}], "PubmedBookArticle": []}